MUN:BMZ

Stock Analysis Report

Executive Summary

BML, Inc. provides laboratory testing and related services in Japan.


Snowflake Analysis

Flawless balance sheet and good value.

Share Price & News

How has BML's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BMZ has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-5.1%

BMZ

-4.4%

DE Healthcare

-6.8%

DE Market


1 Year Return

-3.9%

BMZ

-0.8%

DE Healthcare

6.5%

DE Market

Return vs Industry: BMZ underperformed the German Healthcare industry which returned -0.3% over the past year.

Return vs Market: BMZ underperformed the German Market which returned 6.1% over the past year.


Shareholder returns

BMZIndustryMarket
7 Day-5.1%-4.4%-6.8%
30 Day-2.7%-1.2%-3.7%
90 Day-5.7%-0.8%-3.6%
1 Year-2.6%-3.9%1.0%-0.8%9.8%6.5%
3 Year26.4%21.5%-25.5%-28.2%6.8%-2.6%
5 Year118.4%103.4%-2.1%-7.5%12.5%-2.9%

Price Volatility Vs. Market

How volatile is BML's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is BML undervalued compared to its fair value and its price relative to the market?

33.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: BMZ (€25.12) is trading below our estimate of fair value (€37.65)

Significantly Below Fair Value: BMZ is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: BMZ is good value based on its PE Ratio (19.1x) compared to the Healthcare industry average (36.9x).

PE vs Market: BMZ is good value based on its PE Ratio (19.1x) compared to the German market (20.2x).


Price to Earnings Growth Ratio

PEG Ratio: BMZ is poor value based on its PEG Ratio (4.5x)


Price to Book Ratio

PB vs Industry: BMZ is overvalued based on its PB Ratio (1.6x) compared to the DE Healthcare industry average (1.5x).


Next Steps

Future Growth

How is BML forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

4.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BMZ's forecast earnings growth (4.2% per year) is above the savings rate (-0.4%).

Earnings vs Market: BMZ's earnings (4.2% per year) are forecast to grow slower than the German market (13% per year).

High Growth Earnings: BMZ's earnings are forecast to grow, but not significantly.

Revenue vs Market: BMZ's revenue (3.1% per year) is forecast to grow slower than the German market (5.1% per year).

High Growth Revenue: BMZ's revenue (3.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BMZ's Return on Equity is forecast to be low in 3 years time (8.6%).


Next Steps

Past Performance

How has BML performed over the past 5 years?

9.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BMZ has a high level of non-cash earnings.

Growing Profit Margin: BMZ's current net profit margins (5.6%) are higher than last year (5.6%).


Past Earnings Growth Analysis

Earnings Trend: BMZ's earnings have grown by 9.9% per year over the past 5 years.

Accelerating Growth: BMZ's earnings growth over the past year (5%) is below its 5-year average (9.9% per year).

Earnings vs Industry: BMZ earnings growth over the past year (5%) underperformed the Healthcare industry 6.2%.


Return on Equity

High ROE: BMZ's Return on Equity (8.5%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is BML's financial position?


Financial Position Analysis

Short Term Liabilities: BMZ's short term assets (¥81.7B) exceed its short term liabilities (¥28.3B).

Long Term Liabilities: BMZ's short term assets (¥81.7B) exceed its long term liabilities (¥6.6B).


Debt to Equity History and Analysis

Debt Level: BMZ is debt free.

Reducing Debt: BMZ currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Debt Coverage: BMZ has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: BMZ has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: BMZ has a high level of physical assets or inventory.

Debt Coverage by Assets: BMZ's debt is not covered by short term assets (assets are -23.7x debt).


Next Steps

Dividend

What is BML's current dividend yield, its reliability and sustainability?

1.31%

Current Dividend Yield


Upcoming Dividend Payment

Purchase BML before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield vs Market

company1.3%marketbottom25%1.5%markettop25%3.8%industryaverage1.9%forecastin3Years1.6%

Current dividend yield vs market & industry

Notable Dividend: BMZ's dividend (1.31%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.43%).

High Dividend: BMZ's dividend (1.31%) is low compared to the top 25% of dividend payers in the German market (3.8%).


Stability and Growth of Payments

Stable Dividend: BMZ's dividend payments have been volatile in the past 10 years.

Growing Dividend: BMZ's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.4%), BMZ's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

Kensuke Kondo (53yo)

6.1yrs

Tenure

0

Mr. Kensuke Kondo has been President of BML Inc. since January 2014 and served as its Executive Officer and Assistant General Manager of Administrative Division since October 2011 and has been its Represen ...


Leadership Team

NamePositionTenureCompensationOwnership
Kensuke Kondo
President6.1yrsno data8.38% ¥91.0m
Masaaki Hirose
Senior Executive Officer & Director2.1yrsno data0.033% ¥356.9k
Nobuki Arai
Sr. Managing Executive Officer10.7yrsno data0.15% ¥1.7m
Masato Chikira
Managing Executive Officer7.7yrsno data0.0094% ¥102.0k
Masao Nakagawa
Managing Exec. Officer5.7yrsno data0.0024% ¥25.5k
Satoshi Enomoto
Operating Officer & Director0yrsno data0.0024% ¥25.5k
Yasushi Narabe
Operating Officer & Director2.1yrsno data0.0070% ¥76.5k
Norihisa Takebe
Operating Officer & Director0yrsno data0.0024% ¥25.5k

4.4yrs

Average Tenure

59yo

Average Age

Experienced Management: BMZ's management team is considered experienced (4.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kensuke Kondo
President6.1yrsno data8.38% ¥91.0m
Masaaki Hirose
Senior Executive Officer & Director2.1yrsno data0.033% ¥356.9k
Nobuki Arai
Sr. Managing Executive Officer10.7yrsno data0.15% ¥1.7m
Masato Chikira
Managing Executive Officer7.7yrsno data0.0094% ¥102.0k
Masao Nakagawa
Managing Exec. Officer5.7yrsno data0.0024% ¥25.5k
Satoshi Enomoto
Operating Officer & Director0yrsno data0.0024% ¥25.5k
Yasushi Narabe
Operating Officer & Director2.1yrsno data0.0070% ¥76.5k
Norihisa Takebe
Operating Officer & Director0yrsno data0.0024% ¥25.5k
Kunikatsu Yamamoto
Outside Director0yrsno datano data
Kouichi Sekiya
Outside Director2.1yrsno datano data

5.7yrs

Average Tenure

61yo

Average Age

Experienced Board: BMZ's board of directors are considered experienced (5.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

BML, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: BML, Inc.
  • Ticker: BMZ
  • Exchange: MUN
  • Founded: 1955
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: JP¥130.620b
  • Listing Market Cap: JP¥1.086b
  • Shares outstanding: 42.62m
  • Website: https://www.bml.co.jp

Number of Employees


Location

  • BML, Inc.
  • 5-21-3 Sendagaya
  • Shibuya-ku
  • Tokyo
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
4694TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYNov 1999
BMZMUN (Boerse Muenchen)YesCommon StockDEEURNov 1999

Biography

BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, as well as subsequent test procedures; and provides electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/26 20:54
End of Day Share Price2020/02/26 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.